Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand

Knowledge about the peptide repertoire presented by human leukocyte antigens (HLA) holds the key to unlock target-specific cancer immunotherapies such as adoptive cell therapies or bispecific T cell engaging receptors. Therefore, comprehensive and accurate characterization of HLA peptidomes by mass...

Descripción completa

Detalles Bibliográficos
Autores principales: Fritsche, Jens, Kowalewski, Daniel J., Backert, Linus, Gwinner, Frederik, Dorner, Sonja, Priemer, Martin, Tsou, Chih-Chiang, Hoffgaard, Franziska, Römer, Michael, Schuster, Heiko, Schoor, Oliver, Weinschenk, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Technological Innovation and Resources
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313844/
https://www.ncbi.nlm.nih.gov/pubmed/34129939
http://dx.doi.org/10.1016/j.mcpro.2021.100110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313844/
https://www.ncbi.nlm.nih.gov/pubmed/34129939
http://dx.doi.org/10.1016/j.mcpro.2021.100110

Ejemplares similares